Back to Search
Start Over
A Phase II Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of the ITCC-059 Study
- Source :
- Blood; November 2020, Vol. 136 Issue: 1, Number 1 Supplement 1 p8-9, 2p
- Publication Year :
- 2020
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Volume :
- 136
- Issue :
- 1, Number 1 Supplement 1
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs57291300
- Full Text :
- https://doi.org/10.1182/blood-2020-134774